Gvia-M Tablet 50mg / 850mg

About Gvia-M Tablet 50mg / 850mg

Gvia-M Tablet Uses

• Type 2 diabetes mellitus management alongside diet and exercise
• Improving blood glucose control when metformin alone is not enough
• Add-on therapy for patients already on metformin who need better HbA1c control
• Long term glycemic management in adults with type 2 diabetes

Gvia-M Tablet Benefits

• Combines two complementary diabetes mechanisms in a single tablet
• Reduces the number of daily tablets compared to taking each drug separately
• Supports more consistent blood sugar control after meals
• Generally weight neutral compared with some other diabetes medicines

What Experts Say

Sitagliptin and metformin work through different but complementary pathways to control blood glucose. Metformin lowers hepatic glucose production and improves peripheral insulin sensitivity, while sitagliptin slows the breakdown of incretin hormones, boosting insulin release after meals. Combining both in one tablet supports steadier glycemic control than either drug alone.

The 850mg metformin strength is typically prescribed for patients who need a higher biguanide dose than the 500mg option but are not yet at the maximum 1000mg level. This dose often suits people moving from metformin monotherapy who need added DPP-4 inhibition for adequate HbA1c control, while GI tolerability is monitored closely during dose escalation.

Pakistan carries one of the world's highest burdens of type 2 diabetes, making structured combination therapy an important tool for reaching treatment targets. Physicians generally recommend baseline and periodic renal function testing, along with HbA1c checks every three months, to confirm the combination remains both effective and safe for continued use.

Drug Class

• DPP-4 Inhibitor (Sitagliptin)
• Biguanide (Metformin Hydrochloride)
• Fixed Dose Combination Antidiabetic

Gvia-M Tablet 50mg / 850mg formula

• Sitagliptin + Metformin Hydrochloride

Available forms

• Tablet

How to use Gvia-M Tablet 50mg / 850mg?

• Take Gvia-M tablet with a meal to reduce stomach upset, usually twice daily as directed by the doctor
• Swallow the tablet whole with a glass of water, do not crush or chew it
• Take the two daily doses at similar times each day, for example with breakfast and dinner
• Do not double the dose if a dose is missed, continue with the next scheduled dose
• Continue diet and exercise changes recommended by the doctor alongside this medicine
• Do not stop the medicine without consulting the doctor even if blood sugar improves

Drug Interactions

• Sulfonylureas or Insulin: Combined use raises the risk of low blood sugar, so dose adjustment may be needed.
• Iodinated Contrast Media: Using contrast dye with metformin in the system raises the risk of acute kidney injury and lactic acidosis; the medicine is often paused around such procedures.
• Alcohol: Heavy or frequent alcohol use increases the risk of lactic acidosis and low blood sugar with this combination.
• Cimetidine: This acid reducing medicine can raise metformin blood levels by reducing its clearance from the kidneys.
• Digoxin: Sitagliptin can slightly raise digoxin blood levels, so monitoring is advised in patients taking both.
• Diuretics or Corticosteroids: These medicines can raise blood sugar levels and may reduce how well this combination controls glucose.

Risks and warnings

• Lactic Acidosis: Metformin carries a rare but serious risk of lactic acidosis, more likely in people with kidney impairment, dehydration, sepsis, or heavy alcohol use.
• Kidney Function: Renal function should be checked before starting and periodically during treatment, since reduced kidney function increases metformin accumulation risk.
• Contrast Dye Procedures: Metformin may need to be paused before and after imaging tests using iodinated contrast, since contrast dye can affect kidney function.
• Pancreatitis: Sitagliptin has been linked to rare cases of acute pancreatitis, including severe forms; persistent abdominal pain should be reported immediately.
• Hypersensitivity Reactions: Sitagliptin can rarely cause serious allergic reactions such as swelling of the face or throat, severe skin reactions, or difficulty breathing.
• Vitamin B12 Levels: Long term metformin use can lower vitamin B12 levels, so periodic monitoring is advised, especially with anemia or nerve symptoms.
• Joint Pain: DPP-4 inhibitors like sitagliptin have been associated with severe joint pain in rare cases that may develop soon after starting or after a long treatment period.

Gvia-M Tablet Side Effects

• Nausea
• Mild diarrhea
• Stomach discomfort
• Gas or bloating
• Reduced appetite
• Headache
• Upper respiratory infection symptoms
• Runny or stuffy nose
• Swelling in the hands or feet
• Low blood sugar when combined with other diabetes medicines
• Metallic taste
• Vomiting

Storage Conditions

• Store below 30°C in a cool, dry place away from direct sunlight.
• Keep the tablets in their original blister pack until ready to use.
• Protect from moisture and humidity, avoid storing in the bathroom.
• Keep out of reach of children and pets.